Preclinical Pharmacokinetics

Abstract

The preclinical pharmacokinetics of protein pharmaceuticals is distinctively different from small‐molecule drugs. Understanding the mechanisms and implications of in vivo disposition of macromolecules provides a means for investigating and designing novel drug candidates and delivery systems to optimize exposure‐response relationships or therapeutic efficacy. This article focuses on the different aspects of preclinical pharmacokinetics of protein pharmaceuticals.